Results 241 to 250 of about 43,288,830 (344)
Molecular Oncology, EarlyView.Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon +13 more
wiley +1 more source
Study of Surface Roughness of CsI:Tl Crystals Treated by Various Abrasives
, 2009 I.V. Kilimchuk +5 more
openalex +2 more sources
Coverage and determinants of childhood immunization in Somalia: A systematic review and meta-analysis. [PDF]
Hum Vaccin ImmunotherDirie AM +5 more
europepmc +1 more source
Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin
Molecular Oncology, EarlyView.The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla +10 more
wiley +1 more source
Prevalence of dysglycemia following paediatric cardiac surgery: a systematic review and meta-analysis. [PDF]
BMJ Paediatr OpenAbera EG, Sime H.
europepmc +1 more source